The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Prognostic Significance of Histomorphologic Parameters in Diffuse Malignant Peritoneal Mesothelioma
Abstract
Context. —Diffuse malignant peritoneal mesothelioma is currently regarded as a rare and lethal primary tumor arising from the peritoneal membrane. In the past, treatment plans with variable combinations of surgery and systemic chemotherapy were associated with a median survival of approximately 1 year. Standardized treatments using cytoreductive surgery and perioperative intraperitoneal chemotherapy have extended this survival. Objective. —To critically analyze the prognostic significance of histomorphologic parameters as a determinant of survival. Design. —Sixty-two consecutive patients with diffuse malignant peritoneal mesothelioma in whom data were prospectively accumulated were retrospectively analyzed by 14 different histomorphologic parameters. The influences of these pathologic characteristics on survival were critically statistically evaluated. Results. —In a univariate analysis, histologic type, nuclear/nucleolar size, stroma, depth of invasion into the bowel, atypical mitoses, mitotic index, necrosis, lymph node involvement, and chromatin patterns were found to be significant. In the multivariate analysis, histologic type and nuclear/nucleolar size remained as determinant histomorphologic characteristics. Use of biphasic/sarcomatoid histologic type as a poor prognostic characteristic was limited in that only 8% of patients showed this histology. Conclusions. —Histomorphologic parameters carry prognostic significance in predicting the survival of patients with diffuse malignant peritoneal mesothelioma when treated in a standardized fashion using cytoreductive surgery and perioperative intraperitoneal chemotherapy. Nuclear/nucleolar size was found to be a reliable histomorphologic assessment available to assess prognosis in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the solid variant (Figure S1d) in the epithelioid subtype, which may be a poor prognostic factor in humans,36”
From Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats (2018) · cites this paper as [36]
Citations
Cites
Prognostic significance of morphologic parameters in renal cell carcinoma
Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198210000-00007 · Cited by 2,724
AJCC cancer staging handbook : from the AJCC cancer staging manual
Greene, F. L. (2002) · Springer eBooks · Cited by 657
Feldman, A. L., Libutti, S. K., Pingpank, J. F., Bartlett, D. L., Beresnev, T. H., Mavroukakis, S. A., Steinberg, S. M., Liewehr, D. J., Kleiner, D. E., & Alexander, H. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.150 · Cited by 353
Pathology of malignant mesothelioma
ATTANOOS, R. L., & GIBBS, A. R. (1997) · Histopathology · doi:10.1046/j.1365-2559.1997.5460776.x · Cited by 294
Antman, K. H., Shemin, R. J., RYAN, L. M., Klegar, K., Osteen, R. T., Herman, T., Lederman, G. S., & Jm, C. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.1.147 · Cited by 289
A review of peritoneal mesothelioma at the Washington Cancer Institute
Sugarbaker, P. H., Welch, L. S., Mohamed, F., & Glehen, O. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(03)00045-0 · Cited by 270
Self-citationMulticystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases.
Weiss, S. W., & Tavassoli, F. A. (1988) · PubMed · Cited by 263
Weiss, S. W., & Tavassoli, F. A. (1988) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198810000-00001 · Cited by 260
Ordóñez, N. G. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00005 · Cited by 208
Ordóǹez, N. G. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00006 · Cited by 190
Research works printed but not linked: 3
- Greene, F. L., D. L.Page, and I. D.Fleming. et al. AJCC Cancer Staging Handbook From the AJCC Cancer Staging Manual. 6th ed.New York, NY: Springer; 2002.
- Sugarbaker, P. H., L.Welch, F.Mohamed, and O.Glehen. A review of peritoneal mesothelioma at the Washington Cancer Institute.Surg Oncol Clin North Am2003. 12:605–621.
- van Ruth, S., M. W. G. A.Bronkhorst, F.van Coevorden, and F. A. N.Zoetmulder. Peritoneal benign cystic mesothelioma: a case report and review of literature.Eur J Surg Oncol2002. 28:192–195.
Cited by
Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats
Ohara, Y., Chew, S., Shibata, T., Okazaki, Y., Yamashita, K., & Toyokuni, S. (2018) · Cancer Science · doi:10.1111/cas.13460 · Cited by 28
Hommell-Fontaine, J., Isaac, S., Passot, G., Decullier, E., Traverse-Glehen, A., Cotte, E., You, B., Mohamed, F., Gilly, F. N., Glehen, O., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3077-4 · Cited by 23
Metadata
- Authors
- Cerruto, C. A., Brun, E. A., Chang, D., & Sugarbaker, P. H.
- Affiliations
- From the Department of Pathology, Washington Hospital Center, Washington, DC (Drs Cerruto and Brun); Westat, Rockville, Md (Dr Chang); and the Washington Cancer Institute, Washington, DC (Dr Sugarbaker)
- Venue
- Archives of Pathology & Laboratory Medicine
- Published
- 2006-11
- Volume
- 130
- Issue
- 11
- Pages
- 1654-1661
- ISSN
- 1543-2165
- 0003-9985
- Cited by
- 78
- References
- 31
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic Significance of Histomorphologic Parameters in Diffuse Malignant Peritoneal Mesothelioma. https://app.cochat.ai/papers/10.5858/2006-130-1654-psohpi
- The paper
- Cerruto, C. A., Brun, E. A., Chang, D., & Sugarbaker, P. H. (2006). Prognostic Significance of Histomorphologic Parameters in Diffuse Malignant Peritoneal Mesothelioma. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/2006-130-1654-psohpi
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.